Takeda Pharmaceutical CoTSE:4502 +0.06%65 Days Inventory is 315.31 as of Mar. 2026, which is 13% above its 10-year median of 279.06. GuruFocus rates TSE:4502 with a GF Score™ of 65/100 and a GF Value™ of 円4,535.84 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 919 Drug Manufacturers companies, Takeda Pharmaceutical Co ranks worse than 84.33% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Takeda Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Takeda Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.28.
Takeda Pharmaceutical Co (TSE:4502) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Takeda Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Takeda Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Takeda Pharmaceutical Co Days Inventory Related Terms
Takeda Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (TSE:4502) has a Days Inventory of 315.31 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Takeda Pharmaceutical Co and its competitors. This is 13% above median its historical median of 279.06. Over the past decade, Takeda Pharmaceutical Co's Days Inventory has ranged from 156.80 to 317.16. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #775 out of 919 companies in the Drug Manufacturers industry, placing it in the top 84.3%.
Is Takeda Pharmaceutical Co's Days Inventory too high?
Takeda Pharmaceutical Co's current Days Inventory of 315.31 is 13% above median its 10-year median of 279.06. Over the past 10 years, this metric has ranged from a low of 156.80 to a high of 317.16. The Drug Manufacturers industry median Days Inventory is 164.48. Takeda Pharmaceutical Co's value of 315.31 is 91.7% above this industry median. Based on the distribution chart, Takeda Pharmaceutical Co ranks #775 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #775 out of 919 companies for Days Inventory. This places Takeda Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.48. Takeda Pharmaceutical Co's value of 315.31 is 91.7% above this benchmark. Historically, Takeda Pharmaceutical Co's own Days Inventory has ranged from 156.80 to 317.16 over the past decade. While the company's 10-year median is 279.06 vs. the industry median of 164.48, Takeda Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takeda Pharmaceutical Co's current Days Inventory of 315.31 is 91.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current Days Inventory is 315.31, which is 13% above median its own 10-year median of 279.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,535.84, compared to a current price of 円5,451.00 — trading 20.2% above its estimated fair value. The current Days Inventory is 315.31, which is 13% above median its 10-year median of 279.06 and 91.7% above the Drug Manufacturers industry median of 164.48. Takeda Pharmaceutical Co's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Days Inventory is 315.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円5,451.00 is trading 20.2% above its estimated GF Value™ of 円4,535.84.
GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4502:
Days Inventory: 315.31 (13% above median its 10-year median of 279.06)
GF Value™: 円4,535.84 vs. price of 円5,451.00 (20.2% above fair value)
Industry Position: 91.7% above the Drug Manufacturers median (#775 of 919)
No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
65GF Score
Get the complete analysis for TSE:4502
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4502 has been successfully added to your 
